Results 31 to 40 of about 3,010,400 (203)
Inhibition of stretching-evoked ATP release from bladder mucosa by anticholinergic agents [PDF]
, 2012 Objective: • To determine whether muscarinic receptor antagonism affected stretch-induced release of ATP. Materials and methods: • Mucosal strips, dissected from Guinea pig (male, 450g; n = 10) urinary bladder, were placed in horizontal organ baths ...
Matharu, Rajinder +10 more
core +1 more source
Bladder catheterization as a risk factor for urinary tract infection [PDF]
, 2022 Introduction: Bladder catheterization contributes significantly to the occurrence of urinary tract infections. This is a common problem in health care both in Poland and around the world.
Sylwia Kocur +7 more
core +1 more source
Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome [PDF]
, 2010 Objective: The aim of the study was a prospective assessment of patient-reported side effects in an open-label study after intradetrusor botulinum toxin injections for idiopathic overactive bladder (OAB). Patients and Methods: Botulinum toxin A injection
Mayer, Margit E. +15 more
core +1 more source
Technology in Cancer Research & Treatment, 2020 Objective: We aimed to explore the diagnostic value of microRNA-192 expression in urinary sediment combined with B-ultrasound in the diagnosis of bladder cancer.
Fuquan Jiang PhD +3 more
doaj +1 more source
International Journal of Women's Dermatology, 2021 Lower urinary tract symptomatology is often difficult to categorize if history and investigation focus only on the urinary tract. Disease and dysfunction in organs more posteriorly can often cause or influence such bladder and urethral symptoms ...
Gayle Fischer, MD, Jennifer Bradford, MD
doaj +1 more source
Botulinum toxin-A for the treatment of overactive bladder: UK contributions [PDF]
, 2013 Background: Botulinum toxin-A (BoNT/A) is now established second-line management for refractory overactivebladder (OAB) and recognised in many incontinence guidelines and pathways.
Fowler, CJ +13 more
core +1 more source
Advances in Urology, 2012 Congenital anomalies such as meningomyelocele and diseases/damage of the central, peripheral, or autonomic nervous systems may produce neurogenic bladder dysfunction, which untreated can result in progressive renal damage, adverse physical effects ...
Peter T. Dorsher, Peter M. McIntosh
doaj +1 more source
Congenital Disorders of the Human Urinary Tract: Recent Insights From Genetic and Molecular Studies
Frontiers in Pediatrics, 2019 The urinary tract comprises the renal pelvis, the ureter, the urinary bladder, and the urethra. The tract acts as a functional unit, first propelling urine from the kidney to the bladder, then storing it at low pressure inside the bladder which ...
Adrian S. Woolf +4 more
doaj +1 more source
Long-term Outcomes of Augmentation Enterocystoplasty in Patients With End-Stage Bladder Diseases: A Single-Institute Experience Involving 102 Patients [PDF]
International Neurourology Journal, 2017 Purpose Augmentation enterocystoplasty (AE) has been shown to improve clinical symptoms in patients with end-stage bladder disease (ESBD). Herein, we report the long-term outcomes of a series of patients with different etiologies of ESBD who received AE.
Shu-Yu Wu +2 more
doaj +1 more source
Involvement of Nitric Oxide in Microcirculatory Reactions after Ischemia-Reperfusion of the Rat Urinary Bladder [PDF]
, 2009 Background: Nitric oxide ( NO) plays a role in inflammation. Our aim was to investigate the role of NO in the microcirculatory changes after ischemia-reperfusion (I/R) of the bladder using intravital videomicroscopy (IVM).
Bajory, Z. +9 more
core +1 more source